From social media to leading industry journals, a great deal of ink has been devoted in recent years to a discussion of the decline of the field-based life sciences sales representative. Whether measured by decreasing job counts, declining physician access, or diminishing relative influence, all the indicators are pointing south. Or are they? Perhaps it’s time we paused to take a fresh look at the true state of the profession. More important, a clear-eyed examination of today’s landscape may give us a useful preview of what the life sciences sales role will look like as this decade comes to an end.
Selecting the right multichannel partner for your life sciences contact center program is no simple task. How do you identify qualified suppliers? What criteria should you use to make your final selection? Based on 15 years’ experience as a life sciences contact center, we’ve identified 10 key steps in evaluating contact centers in order to select the one that best suits your needs.
The transition from initial therapy to maintenance therapy often receives minimal focus and remains a largely untapped patient-engagement opportunity. The white paper takes an in-depth look at this subject and how the new emerging clinical health education model is changing the overall value proposition of patient care..
Physicians increasingly want biopharma companies to use a combination of communication channels to deliver the best value for their practices, including higher-quality field sales representatives and a variety of nontraditional representatives. The survey updates a previous one performed by Publicis and Sermo to determine how well the biopharma industry is fulfilling its value proposition to physicians. The survey also examines physicians’ attitudes toward emerging digital and social media.
Today, marketers are working overtime to augment field sales forces with a wide range of field-alternative communicators and an array of established and emerging technologies that create real-time, remote interactions with HCPs. It is crucial that life sciences companies employ a complete, highly customized message delivery mix so they can not only access physicians when and where they want, but also build and strengthen relationships with them.
Clinical Communications Programs with Healthcare Professionals and Patients: A Multichannel Approach
The life sciences industry is continuing to expand the clinical communications function. Despite industry‐wide restructuring and ongoing budget consolidation, in 2011 many companies anticipated an increase in medical affairs funding. This best practices whitepaper explores the market forces driving the expansion of clinical communications programs, common tasks and roles, guidelines for avoiding legal and regulatory pitfalls and more.
Life sciences companies are increasingly turning to MSLs to enhance the full exchange of scientific information between the company and the global medical science community. Today’s MSLs are peer‐to‐peer communicators who contribute to improved patient outcomes. Download the whitepaper to learn about the critical success factors for implementing a Medical Science Liaison Team.
This whitepaper is a resource of frequently asked questions to guide you through regulatory and legal considerations when implementing a clinical health education program.
This whitepaper provides an in-depth guide to the process of establishing a life sciences sales force, including The Basics Checklist, Metrics and Incentive Compensation, Recruiting & HR, Training, SFA, Sampling Administration, and more.